Boston Scientific (BSX) Divestments (2009 - 2022)

Boston Scientific (BSX) has 9 years of Divestments data on file, last reported at $5.0 million in Q1 2022.

• For the quarter ending Q1 2022, Divestments fell 99.38% year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2022 stood at $5.0 million (down 99.39% YoY), and the FY2022 full-year result was $5.0 million, down 99.39% from the prior year.
• Divestments retreated to $5.0 million in Q1 2022, from $25.0 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $801.0 million in Q1 2021 to a low of $5.0 million in Q1 2022.
• A 4-year average of $187.2 million and a median of $25.0 million in 2021 frame the typical range for Divestments.
• Peak annual rise in Divestments reached 99.38% in 2022, while the deepest fall reached 99.38% in 2022.
• Tracing BSX's Divestments over 4 years: stood at $90.0 million in 2019, then sank by 83.33% to $15.0 million in 2020, then soared by 66.67% to $25.0 million in 2021, then plunged by 80.0% to $5.0 million in 2022.
• Business Quant data shows BSX's Divestments at $5.0 million in Q1 2022, $25.0 million in Q4 2021, and $801.0 million in Q1 2021.